NYSE:RAD - Rite Aid Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.95 +0.03 (+1.56 %)
(As of 06/20/2018 04:00 PM ET)
Previous Close$1.95
Today's Range$1.88 - $1.96
52-Week Range$1.38 - $4.21
Volume9.38 million shs
Average Volume19.39 million shs
Market Capitalization$2.03 billion
P/E Ratio-97.50
Dividend YieldN/A
Rite Aid logoRite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail


Debt-to-Equity Ratio2.11
Current Ratio1.37
Quick Ratio0.85


Trailing P/E Ratio-97.50
Forward P/E Ratio48.75
P/E GrowthN/A

Sales & Book Value

Annual Sales$21.53 billion
Price / Sales0.10
Cash Flow$0.6037 per share
Price / Cash3.23
Book Value$1.50 per share
Price / Book1.30


EPS (Most Recent Fiscal Year)($0.02)
Net Income$943.47 million
Net Margins3.60%
Return on Equity-8.25%
Return on Assets-0.71%


Outstanding Shares1,067,390,000

Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) posted its earnings results on Thursday, April, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $5.39 billion for the quarter, compared to analyst estimates of $5.75 billion. Rite Aid had a negative return on equity of 8.25% and a net margin of 3.60%. The business's revenue was down 8.6% on a year-over-year basis. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Wednesday, June, 27th 2018. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its FY19 earnings guidance on Thursday, April, 12th. The company provided EPS guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.03. The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $21.73 billion.

What price target have analysts set for RAD?

8 equities research analysts have issued 12-month price targets for Rite Aid's shares. Their forecasts range from $1.50 to $4.70. On average, they expect Rite Aid's stock price to reach $2.3063 in the next year. View Analyst Ratings for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest in May. As of May 31st, there was short interest totalling 155,351,909 shares, an increase of 5.4% from the May 15th total of 147,439,730 shares. Based on an average trading volume of 8,108,499 shares, the days-to-cover ratio is presently 19.2 days. Currently, 14.7% of the company's shares are sold short. View Rite Aid's Current Options Chain.

Who are some of Rite Aid's key competitors?

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:
  • Mr. John T. Standley, Chairman & CEO (Age 55)
  • Mr. Darren W. Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
  • Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)
  • Mr. Kermit R. Crawford, Pres & COO (Age 59)
  • Mr. Douglas Elwood Donley, Sr. VP & Chief Accounting Officer (Age 56)

Has Rite Aid been receiving favorable news coverage?

News stories about RAD stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rite Aid earned a media sentiment score of 0.18 on Accern's scale. They also assigned news articles about the company an impact score of 47.89 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a number of of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (4.81%), OppenheimerFunds Inc. (4.70%), BlackRock Inc. (4.10%), Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (1.76%), Alpine Associates Management Inc. (0.94%) and Dimensional Fund Advisors LP (0.63%). View Institutional Ownership Trends for Rite Aid.

Which institutional investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., UBS Group AG, Gabelli Funds LLC, California Public Employees Retirement System, SG Americas Securities LLC, Symons Capital Management Inc., New York State Common Retirement Fund and Teacher Retirement System of Texas. View Insider Buying and Selling for Rite Aid.

Which institutional investors are buying Rite Aid stock?

RAD stock was acquired by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Franklin Resources Inc., Millennium Management LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Dimensional Fund Advisors LP, Interval Partners LP, Nuveen Asset Management LLC and BlackRock Inc.. View Insider Buying and Selling for Rite Aid.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $1.95.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $2.03 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]

MarketBeat Community Rating for Rite Aid (RAD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  382 (Vote Outperform)
Underperform Votes:  387 (Vote Underperform)
Total Votes:  769
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.